Literature DB >> 9444560

Effect of monoamine oxidase A and B and of catechol-O-methyltransferase inhibition on L-DOPA-induced circling behavior.

M J Heeringa1, F d'Agostini, P DeBoer, M DaPrada, G Damsma.   

Abstract

The effect of enzyme-inhibiting adjuvants on L-DOPA + benserazide-induced contralateral turning in unilateral 6-hydroxydopamine (6-OHDA)-lesioned rats was studied. Both the number of turns and the duration of turning were examined. Inhibition of MAO-A with 10 mg/kg Ro 41-1049 increased both parameters; inhibition of COMT with 30 mg/kg Ro 40-7592 had a similar effect. In contrast, inhibition of MAO-B with 10 mg/kg Ro 19-6327 did not change turning behavior. A further potentiation of turning behavior was observed after the combined administration of both the MAO-A and COMT inhibitor. MAO-A inhibition in conjunction with MAO-B inhibition prolonged the duration of L-DOPA-induced turning but had no effect on the number of turns. However, in conjunction with COMT inhibition, 10 mg/kg of the MAO-B inhibitor, Ro 19-6327, significantly affected both the number and duration of turning behavior. An even further potentiation of turning behavior was observed after the combined administration of all three enzyme-inhibitors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9444560     DOI: 10.1007/BF01291878

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  51 in total

Review 1.  Catechol-O-methyl transferase: pharmacological aspects and physiological role.

Authors:  H C Guldberg; C A Marsden
Journal:  Pharmacol Rev       Date:  1975-06       Impact factor: 25.468

Review 2.  From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors.

Authors:  M Da Prada; R Kettler; H H Keller; A M Cesura; J G Richards; J Saura Marti; D Muggli-Maniglio; P C Wyss; E Kyburz; R Imhof
Journal:  J Neural Transm Suppl       Date:  1990

3.  Turning in MFB-lesioned rats and antagonism of neuroleptic-induced catalepsy after lisuride and LSD.

Authors:  M Pieri; R Schaffner; L Pieri; M Da Prada; W Haefely
Journal:  Life Sci       Date:  1978-05-08       Impact factor: 5.037

4.  Some puzzling pharmacological effects of monoamine oxidase inhibitors.

Authors:  J Knoll; K Magyar
Journal:  Adv Biochem Psychopharmacol       Date:  1972

5.  A controlled trial of lazabemide (Ro 19-6327) in levodopa-treated Parkinson's disease. Parkinson Study Group.

Authors: 
Journal:  Arch Neurol       Date:  1994-04

6.  Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase.

Authors:  J A Roth; K Feor
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

7.  Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study.

Authors:  A Colzi; F d'Agostini; R Kettler; E Borroni; M Da Prada
Journal:  J Neural Transm Suppl       Date:  1990

8.  Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592.

Authors:  E Acquas; E Carboni; R H de Ree; M Da Prada; G Di Chiara
Journal:  J Neurochem       Date:  1992-07       Impact factor: 5.372

9.  The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian properties.

Authors:  J D Elsworth; M Sandler; A J Lees; C Ward; G M Stern
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

10.  Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.

Authors:  F Karoum; L W Chuang; T Eisler; D B Calne; M R Liebowitz; F M Quitkin; D F Klein; R J Wyatt
Journal:  Neurology       Date:  1982-05       Impact factor: 9.910

View more
  3 in total

1.  Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.

Authors:  Kirsten E Culver; Henry Szechtman
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

2.  Locomotor effects of imidazoline I2-site-specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway.

Authors:  Nicholas Macinnes; Susan Duty
Journal:  Br J Pharmacol       Date:  2004-11-15       Impact factor: 8.739

3.  Behavioural Assessment of the A2a/NR2B Combination in the Unilateral 6-OHDA-Lesioned Rat Model: A New Method to Examine the Therapeutic Potential of Non-Dopaminergic Drugs.

Authors:  Anne Michel; Patrick Downey; Xavier Van Damme; Catherine De Wolf; Rainer Schwarting; Dieter Scheller
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.